Skip to content

Virtual Reality Based Vision Test in Patients With AMD

Virtual Reality (VR) Based Vision Test in Subjects With Age-related Macular Degeneration (AMD)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06241625
Acronym
GA-001
Enrollment
50
Registered
2024-02-05
Start date
2022-10-20
Completion date
2024-07-31
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age-Related Macular Degeneration

Brief summary

To assess the usability, tolerability, and repeatability of the set of VR headset-based tasks.

Detailed description

In order to bridge the gap between the existing functional measures and AMD lesions, researchers are considering the use of VR tools. This study is designed to assess the contrast sensitivity function mapping test (CSF radial sweep) in an elderly population with AMD. The primary objective of this study is to assess the usability, tolerability, and repeatability of the set of VR headset-based tasks. The secondary objective of this study is to assess the relationship between the metrics generated by VR-based functional tasks and the metrics derived from conventional clinical measurements of retinal anatomy and visual function. The primary efficacy endpoint is the Contrast sensitivity function (CSF) area under curve (AUC) correlation to Snellen BCVA.

Interventions

DIAGNOSTIC_TESTVirtual Reality (VR) Contrast Function Test

Patients perform a new Virtual Reality (VR) Contrast Function Test

Sponsors

Apellis Pharmaceuticals, Inc.
CollaboratorINDUSTRY
Augenklinik Zurich West
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 105 Years
Healthy volunteers
No

Inclusion criteria

1. Subjects ≥18 years of age diagnosed with AMD 2. Subject Snellen BCVA score is 20/100 or better 3. Ability to undergo quality optical coherence tomography (OCT) imaging 4. Willing and able to give written informed consent

Exclusion criteria

1. Unwilling to use headset 2. Previous negative experience with a VR headset (eg, motion sickness, discomfort) 3. Any known oculomotor impairment that would impact the ability of the subject to perform the tasks (eg, nystagmus, proptosis, apraxia of eyelid opening) 4. Any manifest neurological or cognitive condition that would impair the subject's understanding or performance on the test (eg, Alzheimer's disease, Parkinson's disease) 5. Any physical limitations that would prohibit the use of the VR headset (eg, neck problems)

Design outcomes

Primary

MeasureTime frameDescription
Usability, tolerability and repeatability20 minutesThe primary objective of this study is to assess the usability, tolerability, and repeatability of the set of VR headset-based tasks. To assess the usability and tolerability a patient survey is performed.

Secondary

MeasureTime frameDescription
Contrast sensitivity function (CSF)10 minutesContrast sensitivity function (CSF) in decibel as area under curve (AUC). The CSF is also correlated to Snellen best corrected visual acuity (BCVA)

Countries

Switzerland

Contacts

Primary ContactStephan Michels, MD
info@augenklinik-zh.ch+414454517

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026